336 related articles for article (PubMed ID: 35143601)
1. Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
Kam W; Holmes DN; Hernandez AF; Saver JL; Fonarow GC; Smith EE; Bhatt DL; Schwamm LH; Reeves MJ; Matsouaka RA; Khan YM; Unverdorben M; Birmingham MC; Lyden PD; Asimos AW; Altschul D; Schoonover TL; Jumaa MA; Nomura JT; Suri MFK; Moore SA; Lafranchise EF; Olson D; Peterson ED; Xian Y
JAMA; 2022 Feb; 327(8):760-771. PubMed ID: 35143601
[TBL] [Abstract][Full Text] [Related]
2. Risk of Bleeding Following Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Acute Ischemic Stroke Treated With Alteplase.
Tsai TY; Liu YC; Huang WT; Tu YK; Qiu SQ; Noor S; Huang YC; Chou EH; Lai EC; Huang HK
JAMA Intern Med; 2024 Jan; 184(1):37-45. PubMed ID: 37983035
[TBL] [Abstract][Full Text] [Related]
3. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.
Xian Y; Federspiel JJ; Hernandez AF; Laskowitz DT; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Peterson ED
Circulation; 2017 Mar; 135(11):1024-1035. PubMed ID: 28119380
[TBL] [Abstract][Full Text] [Related]
4. Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.
Jin C; Huang RJ; Peterson ED; Laskowitz DT; Hernandez AF; Federspiel JJ; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Xian Y
Stroke; 2018 Sep; 49(9):2237-2240. PubMed ID: 30354981
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY
JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708
[TBL] [Abstract][Full Text] [Related]
6. Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke.
Mac Grory B; Holmes DN; Matsouaka RA; Shah S; Chang CWJ; Rison R; Jindal J; Holmstedt C; Logan WR; Corral C; Mackey JS; Gee JR; Bonovich D; Walker J; Gropen T; Benesch C; Dissin J; Pandey H; Wang D; Unverdorben M; Hernandez AF; Reeves M; Smith EE; Schwamm LH; Bhatt DL; Saver JL; Fonarow GC; Peterson ED; Xian Y
JAMA; 2023 Jun; 329(23):2038-2049. PubMed ID: 37338878
[TBL] [Abstract][Full Text] [Related]
7. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
[TBL] [Abstract][Full Text] [Related]
8. Outcomes After Endovascular Thrombectomy With or Without Alteplase in Routine Clinical Practice.
Smith EE; Zerna C; Solomon N; Matsouaka R; Mac Grory B; Saver JL; Hill MD; Fonarow GC; Schwamm LH; Messé SR; Xian Y
JAMA Neurol; 2022 Aug; 79(8):768-776. PubMed ID: 35696198
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants.
Okada T; Yoshimoto T; Wada S; Yoshimura S; Chiba T; Egashira S; Kimura S; Shiozawa M; Inoue M; Ihara M; Toyoda K; Takashima H; Koga M
J Am Heart Assoc; 2022 Oct; 11(19):e025809. PubMed ID: 36129032
[TBL] [Abstract][Full Text] [Related]
10. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
[TBL] [Abstract][Full Text] [Related]
11. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
[TBL] [Abstract][Full Text] [Related]
12. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
[TBL] [Abstract][Full Text] [Related]
13. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants.
Meinel TR; Wilson D; Gensicke H; Scheitz JF; Ringleb P; Goganau I; Kaesmacher J; Bae HJ; Kim DY; Kermer P; Suzuki K; Kimura K; Macha K; Koga M; Wada S; Altersberger V; Salerno A; Palanikumar L; Zini A; Forlivesi S; Kellert L; Wischmann J; Kristoffersen ES; Beharry J; Barber PA; Hong JB; Cereda C; Schlemm E; Yakushiji Y; Poli S; Leker R; Romoli M; Zedde M; Curtze S; Ikenberg B; Uphaus T; Giannandrea D; Portela PC; Veltkamp R; Ranta A; Arnold M; Fischer U; Cha JK; Wu TY; Purrucker JC; Seiffge DJ; ; ; Kägi G; Engelter S; Nolte CH; Kallmünzer B; Michel P; Kleinig TJ; Fink J; Rønning OM; Campbell B; Nederkoorn PJ; Thomalla G; Kunieda T; Poli K; Béjot Y; Soo Y; Garcia-Esperon C; Ntaios G; Cordonnier C; Marto JP; Bigliardi G; Lun F; Choi PMC; Steiner T; Ustrell X; Werring D; Wegener S; Pezzini A; Du H; Martí-Fàbregas J; Cánovas-Vergé D; Strbian D; Padjen V; Yaghi S; Stretz C; Kim JT
JAMA Neurol; 2023 Mar; 80(3):233-243. PubMed ID: 36807495
[TBL] [Abstract][Full Text] [Related]
15. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.
Bala F; Singh N; Buck B; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Appireddy R; Moreau F; Phillips S; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Williams H; Field TS; Manosalva Alzate A; Siddiqui M; Zafar A; Imoukhoude O; Hunter G; Alhabli I; Benali F; Horn M; Hill MD; Shamy M; Sajobi TT; Swartz RH; Menon BK; Almekhlafi M
JAMA Neurol; 2023 Aug; 80(8):824-832. PubMed ID: 37428494
[TBL] [Abstract][Full Text] [Related]
17. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.
van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Postma AA; Roosendaal SD; Krietemeijer GM; Yo LSF; de Maat MPM; Nieboer D; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
JAMA Neurol; 2023 Jul; 80(7):714-722. PubMed ID: 37213122
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Tirofiban Versus Alteplase Before Endovascular Treatment in Acute Ischemic Stroke: A Pooled Analysis of the DEVT and RESCUE BT Trials.
Sang H; Cao Z; Du J; Nguyen TN; Saver JL; Mao A; Nogueira RG; Tao Z; Zhou S; Han Q; Sun D; Lei B; Liu S; Zeng G; Yin C; Xie D; Luo W; Jin Z; Qiu Z;
Stroke; 2024 Apr; 55(4):856-865. PubMed ID: 38362756
[TBL] [Abstract][Full Text] [Related]
20. Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Rose D; Cavalier A; Kam W; Cantrell S; Lusk J; Schrag M; Yaghi S; Stretz C; de Havenon A; Saldanha IJ; Wu TY; Ranta A; Barber PA; Marriott E; Feng W; Kosinski AS; Laskowitz D; Poli S; Mac Grory B
Stroke; 2023 May; 54(5):1192-1204. PubMed ID: 36951049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
